The observation that AC is overexpressed in pediatric brain tumor lines resistant to chemo- and radiotherapy [94] led to the development and testing of carmofur, a potent AC inhibitor and chemotherapeutic agent in these neoplastic cells. This evidence concerns the gene ASAH1 and brain neoplasm.